BUSPIRONE IN PARKINSONS-DISEASE

被引：30

作者：

HAMMERSTAD, JP ^{[1
]}

CARTER, J ^{[1
]}

NUTT, JG ^{[1
]}

CASTEN, GC ^{[1
]}

SHROTRIYA, RC ^{[1
]}

ALMS, DR ^{[1
]}

TEMPLE, D ^{[1
]}

机构：

[1] BRISTOL MYERS CO,DIV PHARMACEUT RES & DEV,EVANSVILLE,IN

来源：

CLINICAL NEUROPHARMACOLOGY | 1986年 / 9卷 / 06期

关键词：

D O I：

10.1097/00002826-198612000-00007

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：556 / 560

页数：5

共 7 条

[1]

GOLDBERG HL, 1979, AM J PSYCHIAT, V136, P1184

[2]

Lieberman A, 1980, Adv Biochem Psychopharmacol, V23, P277

[3] BUSPIRONE, PARKINSONS-DISEASE, AND THE LOCUS-CERULEUS [J].

LUDWIG, CL ;

WEINBERGER, DR ;

BRUNO, G ;

GILLESPIE, M ;

BAKKER, K ;

LEWITT, PA ;

CHASE, TN .

CLINICAL NEUROPHARMACOLOGY, 1986, 9 (04) :373-378

[4]

MCMILLEN BA, 1983, J NEUROSCI, V3, P733

[5] SELECTIVE EFFECTS OF BUSPIRONE AND MOLINDONE ON DOPAMINE METABOLISM AND FUNCTION IN THE STRIATUM AND FRONTAL-CORTEX OF THE RAT [J].

MCMILLEN, BA ;

MCDONALD, CC .

NEUROPHARMACOLOGY, 1983, 22 (03) :273-278

[6] BUSPIRONE ENHANCES [H-3]-LABELED FLUNITRAZEPAM BINDING INVIVO [J].

OAKLEY, NR ;

JONES, BJ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 87 (04) :499-500

[7]

RIBLET LA, 1982, J CLIN PSYCHIAT, V43, P11

← 1 →